Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179022-04-000022
Filing Date
2004-01-09
Accepted
2004-01-09 11:42:11
Documents
1
Period of Report
2004-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3046
  Complete submission text file 0001179022-04-000022.txt   4923
Mailing Address 420 LEXINGTON AVE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 601 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 4170 MENDENHALL OAKS PARKWAY SUITE 110 HIGHPOINT NC 27265 3368410300
MJALLI ADNAN M M (Reporting) CIK: 0001275596 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23047 | Film No.: 04517005